1. Home
  2. RC vs LFCR Comparison

RC vs LFCR Comparison

Compare RC & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ready Capital Corproation

RC

Ready Capital Corproation

HOLD

Current Price

$1.94

Market Cap

299.9M

Sector

Real Estate

ML Signal

HOLD

Logo Lifecore Biomedical Inc.

LFCR

Lifecore Biomedical Inc.

HOLD

Current Price

$6.97

Market Cap

269.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RC
LFCR
Founded
2007
1986
Country
United States
United States
Employees
475
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
299.9M
269.8M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
RC
LFCR
Price
$1.94
$6.97
Analyst Decision
Hold
Buy
Analyst Count
4
2
Target Price
$2.81
N/A
AVG Volume (30 Days)
2.6M
115.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.94%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$557,559,000.00
Revenue This Year
N/A
$2.80
Revenue Next Year
$67.36
$11.51
P/E Ratio
N/A
N/A
Revenue Growth
N/A
6.36
52 Week Low
$1.55
$4.76
52 Week High
$5.48
$8.98

Technical Indicators

Market Signals
Indicator
RC
LFCR
Relative Strength Index (RSI) 48.83 36.07
Support Level $1.60 $6.55
Resistance Level $2.42 $7.03
Average True Range (ATR) 0.15 0.28
MACD 0.05 -0.00
Stochastic Oscillator 60.83 39.76

Price Performance

Historical Comparison
RC
LFCR

About RC Ready Capital Corproation

Ready Capital Corp is a real estate finance company. It acquires, manages, originates, and finances small-balance commercial loans to purchase small multi-family, office, retail, mixed-use, or warehouse properties. The company's segments consist of LMM Commercial Real Estate and Small Business Lending. It generates the majority of its revenue from LMM Commercial Real Estate.

About LFCR Lifecore Biomedical Inc.

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.

Share on Social Networks: